Novus Acquisition & Development (Novus Acquisition & Development) EBITDA Margin % : 45.35% (As of Sep. 2023)

View and export this data going back to . Start your Free Trial

What is Novus Acquisition & Development EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Novus Acquisition & Development's EBITDA for the three months ended in Sep. 2023 was $0.04 Mil. Novus Acquisition & Development's Revenue for the three months ended in Sep. 2023 was $0.09 Mil. Therefore, Novus Acquisition & Development's EBITDA margin for the quarter that ended in Sep. 2023 was 45.35%.

Novus Acquisition & Development EBITDA Margin % Historical Data

The historical data trend for Novus Acquisition & Development's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novus Acquisition & Development EBITDA Margin % Chart

Novus Acquisition & Development Annual Data

Trend

EBITDA Margin %

Novus Acquisition & Development Quarterly Data
	Sep22	Sep23
EBITDA Margin %	38.96	45.35

Competitive Comparison of Novus Acquisition & Development's EBITDA Margin %

For the Insurance - Diversified subindustry, Novus Acquisition & Development's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novus Acquisition & Development's EBITDA Margin % Distribution in the Insurance Industry

For the Insurance industry and Financial Services sector, Novus Acquisition & Development's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Novus Acquisition & Development's EBITDA Margin % falls into.

Novus Acquisition & Development EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Novus Acquisition & Development's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %	=	EBITDA (A: . 20 )	/	Revenue (A: . 20 )
	=		/
	=	%

Novus Acquisition & Development's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	0.039	/	0.086
	=	45.35 %

Novus Acquisition & Development (OTCPK:NDEV) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Novus Acquisition & Development EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Novus Acquisition & Development's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Novus Acquisition & Development (Novus Acquisition & Development) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Novus Acquisition & Development Corp (OTCPK:NDEV) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2665 South Bayshore Drive, Suite 220, Miami, FL, USA, 33131

Website

https://www.getnovusnow.com

Novus Acquisition & Development Corp is a holding company operating through its subsidiaries. It offers health, life, and annuity insurance products and services. The company initiated its health insurance business model within the medical marijuana space, where it can render risk and non-risk insurance models. It operates throughout the United States.